IP Library Granted Patent US 9,180,294
Granted Patent B2
US 9,180,294 · App. 14/352,594 · Granted Nov 10, 2015

Electrical stimulation device having multiple stimulation channels

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,180,294
App. No.
14/352,594
Granted
Nov 10, 2015
Kind
B2
Abstract

An implantable electrical stimulation device configured to treat multiple pelvic conditions of a patient includes a pulse generator, memory, first and second electrode leads comprising one or more electrodes, a switch and a controller. The switch has a first state, in which the first electrode lead is electrically coupled to the pulse generator, and a second state, in which the second electrode lead is electrically coupled to the pulse generator. The controller includes at least one processor that is configured to execute at least one stimulation program stored in the memory. The controller is also configured to selectively set the switch in the first or second state. Electrical stimulation pulses generated by the pulse generator responsive to the execution of the stimulation program are delivered to the first or second electrode lead depending on the state of the switch.

Claims (44)

1. Implantable electrical stimulation device comprising:

a pulse generator;

memory containing a first stimulation program and a second stimulation program;

first and second electrode leads each comprising one or more electrodes;

a switch having a first state in which the first electrode lead is electrically coupled to the pulse generator, and a second state in which the second electrode lead is electrically coupled to the pulse generator; and

a controller comprising at least one processor configured to execute the first and second stimulation programs stored in the memory, the controller configured to selectively set the switch in the first or second state;

wherein:

electrical stimulation pulses generated by the pulse generator are delivered to the first electrode lead responsive to the execution of the first stimulation program by at least one processor when the switch is in the first state;

electrical stimulation pulses generated by the pulse generator and delivered to the second electrode lead responsive to the execution of the second stimulation program by the at least one processor when the switch is in the second state;

the stimulation pulses generated by the pulse generator in response to the execution of the first stimulation program are configured to treat a first pelvic condition; and

the stimulation pulses produced by the pulse generator in response to the execution of the second stimulation program are configured to treat a second pelvic condition that is different from the first pelvic condition.

2. The device of claim 1 , wherein the first and second pelvic conditions are selected from the group consisting of urinary incontinence, fecal incontinence, pain due to interstitial cystitis and urine retention.

3. An implantable electrical stimulation device comprising:

first and second pulse generators;

memory containing a first stimulation program and a second stimulation program; and

a controller comprising at least one processor configured to execute the first and second stimulation programs stored in the memory;

wherein:

the first pulse generator produces stimulation pulses responsive to the execution of the first stimulation program by the at least one processor;

the second pulse generator produces stimulation pulses responsive to the execution of the second stimulation program by the at least processor;

the stimulation pulses produced by the first pulse generator in response to the execution of the first stimulation program are configured to treat a first pelvic condition; and

the stimulation pulses produced by the second pulse generator in response to the execution of the second stimulation program are configured to treat a second pelvic condition that is different the first pelvic condition.

4. The device of claim 3 , wherein the first and second pelvic conditions are selected from the group consisting of urinary incontinence, fecal incontinence, pain due to interstitial cystitis and urine retention.

5. The device of claims 3 , further comprising:

at least a first electrode lead comprising one or more electrodes electrically coupled to the first pulse generator; and

at least a second electrode lead comprising one or more electrodes electrically coupled to the second pulse generator.

6. A method of treating pelvic conditions of a patient comprising:

implanting an electrical stimulation device comprising a control unit and first and second electrode leads in a patient, wherein the first electrode lead comprises one or more electrodes positioned at a first stimulation site, and the second electrode lead comprises one or more electrodes positioned at a second stimulation site that is different from the first stimulation site;

performing a first stimulation treatment comprising delivering electrical stimulation signals to the first stimulation site through the first electrode lead;

treating a first pelvic condition of the patient responsive to the first stimulation treatment;

performing a second stimulation treatment comprising delivering electrical stimulation signals to the second stimulation site through the second electrode lead; and

treating a second pelvic condition of the patient responsive to the second stimulation treatment.

7. The method of claim 6 , wherein:

the control unit comprises a first pulse generator electrically coupled to the first electrode lead, and a second pulse generator electrically coupled to the second electrode lead;

performing a first stimulation treatment comprises generating electrical stimulation pulses using the first pulse generator and delivering the electrical stimulation pulses to the first stimulation site through the first electrode lead;

performing a second stimulation treatment comprises generally generating electrical stimulation pulses using the second pulse generator and delivering the electrical stimulation pulses to the second stimulation site through the second electrode lead.

8. The method of claim 6 , wherein:

the control unit comprises a pulse generator and a switch having a first state in which the pulse generator is electrically coupled to the first electrode lead, and a second state in which the pulse generator is electrically coupled to the second electrode lead;

performing a first stimulation treatment comprises placing the switch in the first state, generating electrical stimulation pulses using the pulse generator, and delivering the electrical stimulation pulses to the first stimulation site through the first electrode lead;

performing a second stimulation treatment comprises placing the switch in the second state, generating electrical stimulation pulses using the pulse generator, and delivering the stimulation pulses to the second stimulation site through the second electrode lead.

9. The method of claims 6 , wherein implanting electrical stimulation device comprises implanting the one or more electrodes of the first electrode lead in the urinary sphincter of the patient, and implanting the one or more electrodes of the second electrode lead in the anal sphincter of the patient.

10. The method of claim 9 , wherein:

treating a first pelvic condition of the patient comprises treating urinary incontinence; and

treating a second pelvic condition of the patient comprises treating fecal incontinence.

11. The method of claim 6 , wherein the first and second pelvic conditions are selected from the group consisting of urinary incontinence, fecal incontinence, pain due to interstitial cystitis and urine retention.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043780/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043778/0302 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0425 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0535 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0607. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 11, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037514/0402 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2014
From: YONCE, DAVID J.
To: AMS RESEARCH CORPORATION
Reel/Frame 032706/0775 →